Common use of AUTOLOGOUS HEMOPOETIC STEM CELL TRANSPLANTATION Clause in Contracts

AUTOLOGOUS HEMOPOETIC STEM CELL TRANSPLANTATION. The autologous hemopoetic stem cell Transplant Services are segregated into the following components: a) TRANSPLANT EVALUATION PHASE. Begins with initial consult with transplant physician through day prior to myeoloblative or immunoablative therapy beginning. This phase ends upon acceptance or denial into the transplant program. The Evaluation Phase shall include: • Consultation with transplant physician(s), psychiatrist(s), specialist(s), transplant coordinator(s), social services. • Hematology, blood banking, serology, chemistry, histocompatibility. • X-rays, pulmonary function tests, skin tests, leukopheresis consultation, CT scan, tissue typing, MRI. • Restaging of disease • Inpatient or outpatient, including professional, room and board, nursing, pharmacy and all other ancillary services. • IV or oral medications for mobilization • Bone marrow harvest/stem cell collection • Stem cell cryopreservation and storage

AUTOLOGOUS HEMOPOETIC STEM CELL TRANSPLANTATION. The autologous hemopoetic stem cell Transplant Services are arc segregated into the following components: a) TRANSPLANT EVALUATION PHASE. Begins with initial consult with transplant physician through day prior to myeoloblative or immunoablative therapy beginning. This phase ends upon acceptance or denial into the transplant program. The Evaluation Phase shall include: • Consultation with transplant physician(s), psychiatrist(s), specialist(s), transplant coordinator(s), social services. • Hematology, blood banking, serology, chemistry, histocompatibility. • X-rays, pulmonary function tests, skin tests, leukopheresis consultation, CT scan, tissue typing, MRI. • Restaging of disease • Inpatient or outpatient, including professional, room and board, nursing, pharmacy and all other ancillary services. • IV or oral medications for mobilization • Bone marrow harvest/stem cell collection • Stem cell cryopreservation and storage